C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
12/1999
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	DE19826213A1 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New antiestrogens, processes for their preparation and their pharmaceutical use
12/16/1999	CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999	CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/15/1999	EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999	EP0963972A2 Stereoselective reduction of carbonyl compounds
12/15/1999	CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999	CN1238760A N-(aryl/heteroaryl/alkyl acetyl) amino acid esters, pharmaceutical composition comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/15/1999	CN1238688A Thiol sulfonamide metalloprotease inhibitors
12/15/1999	CN1238327A Stereoselective reduction of carbonyl compounds
12/15/1999	CA2274365A1 Compounds and compositions containing them useful for the transfer of active substances into a cell
12/15/1999	CA2274212A1 Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
12/14/1999	US6002013 2-amino-7-carboxybenzothiazole derivatives
12/14/1999	US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/14/1999	US6001880 Disubstituted n-(2-dialkylaminoethyl)benzamide derivatives of given formula; antibacterial activity against helicobacter pyroli, administering for the prevention or cure of peptic ulcers
12/14/1999	US6001877 Of given formula, which acts as an antagonist of leukotrienes; administering to treat leukotriene-b4 induced diseases, such as allergies and inflammation
12/14/1999	US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/14/1999	US6001786 A thiophenol stabilizer is prepared by reacting at least two different chlorine-free hindered phenols, a chlorine-free sulfur source and alkali metal hydroxide promoter in propanol solvent; for lubricating oils and liquid organic fuels
12/09/1999	WO1999062962A1 Novel photoinitiators and applications therefor
12/09/1999	WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999	WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999	WO1999062874A1 Trifluoro methylthiomethyl benzene derivatives and process for producing the same
12/09/1999	WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999	WO1999062871A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999	WO1999062870A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	WO1999062520A1 Hiv integrase inhibitors
12/09/1999	WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999	WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999	DE19824488A1 Verfahren zur Herstellung von Perfluoralkyl-aryl-sulfiden und neue Perfluoralkyl-aryl-sulfide Process for preparing perfluoroalkyl aryl sulphides and new perfluoroalkyl aryl sulphides
12/09/1999	CA2334374A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999	CA2334107A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	CA2333707A1 Hiv integrase inhibitors
12/09/1999	CA2298468A1 Novel photoinitiators and applications therefor
12/09/1999	CA2273643A1 Stereoselective reduction of carbonyl compounds
12/08/1999	EP0962450A1 Process for the preparation of perfluoalkylaryl sulfides and perfluoroalkylaryl sulfides per se
12/08/1999	EP0961769A1 Process for the preparation of 2-hydroxy-4-(methylthio)butanoic acid or methionine by mercaptan addition
12/08/1999	EP0961766A1 Phenoxyacetic acid derivatives and their use as herbicides
12/08/1999	EP0787124B1 Process for the preparation of substituted 3-aminobenzonitriles
12/08/1999	EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999	EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999	CN1237967A Processes and intermediates for preparation of oxazoline derivatives
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999	CN1237960A N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999	CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999	CN1237580A Phosphononooxymethyl ethers of taxame derivatives
12/08/1999	CN1237577A Method for refining carbamates compound
12/07/1999	US5998670 By-product inhibition; reacting thiophenol with hydrogen peroxide
12/07/1999	US5998667 Chemical intermediate for insecticides, miticides
12/07/1999	US5998664 Continuous hydrolysis process for the preparation of 2-hydroxy-4-methylthiobutanoic acid
12/07/1999	US5998655 Alkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/07/1999	US5998637 Process for preparing optically active trans-3-substituted glycidic acid ester
12/07/1999	US5998636 Carbamate herbicides
12/07/1999	US5998564 Curing agent for fluoropolymers
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998471 Skin disorders; antiinflammatory agents
12/07/1999	US5998466 Preplanting
12/07/1999	US5998417 N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds and their therapeutic utility
12/07/1999	US5997610 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides
12/07/1999	CA2000925C Mercaptobenzoates as stabilisers for chlorine-containing polymers
12/02/1999	WO1999061416A1 Substituted dithio-bis-nitrobenzenes and their applications
12/02/1999	WO1999061414A1 Novel substituted guanidine derivatives and process for producing the same
12/02/1999	WO1999061413A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
12/02/1999	CA2331509A1 Novel substituted guanidine derivatives and process for producing the same
12/02/1999	CA2273637A1 Process for preparing perfluoroalkyl aryl sulfides and novel perfluoroalkyl aryl sulfides
12/01/1999	EP0960906A1 Bis(Hydroxyalkyl Alkyl Ester) Polysulfides
12/01/1999	EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999	EP0850253B1 Betaketosulfonic derivatives suitable to the use as polymerization photoinitiators and photopolymerizable systems containing the same
12/01/1999	EP0582631B1 Use of S-nitrosothiols for the preparation of a medicament for the relaxation of smooth muscle
11/1999
11/30/1999	US5994588 Peptide purification method using novel linker and solid-phase ligand
11/30/1999	US5994539 Mercapto acyl aminoacid derivatives endowed with dual ACE-NEP inhibitory activity, useful in the treatment of cardiovascular diseases

1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 272